Novo Nordisk A/S
Long

NOVO is looking at a strong bullish bottoming out

155
NVO is looking at a strong bullish reversal and is likely to head higher after stochastic shows overbought AND long term stochastic shows clear confirmation of oversold crossover.

Price action shows a clear break out of the downtrend line and with the rounding bottom, the stock is likely to target 101 in near to mid-term.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.